RxDoctor Payments Data

Carmen Janich

Adult Health · Aurora, ILNPI 1205173903

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 188 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 12 manufacturers reported payments, led by AbbVie at 30.5% of the total. Among adult health clinicians in IL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$5,099in general payments, 2019–2025

Across 188 payments — averaging $27.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Boehringer Ingelheim$1K
  • AstraZeneca$1K
  • Lilly USA, LLC$626
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$192
  • Bayer$69
  • plus $151 from 6 others

What the payments were for

  • Food & beverage$5,099100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,099 in reported general payments places this provider in the 90th percentile of 553 adult health providers in Illinois.

See all adult health providers in Illinois

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin48$62,756
FarxigaDapagliflozin Propanediol35$32,502
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog24$7,716
Humalog Mix 50-50 KwikpenInsulin Lispro Protamin/Lispro12$3,559
Lantus SolostarInsulin Glargine,hum.Rec.Anlog19$2,636
LantusInsulin Glargine,hum.Rec.Anlog13$2,054
Gabapentin57$1,112
Labetalol Hcl35$1,043
Levothyroxine Sodium81$902
Insulin SyringeSyringe And Needle,insulin,1ml14$798
Fenofibrate13$725
Tamsulosin Hcl27$530
Metformin Hcl122$519
Albuterol Sulfate HfaAlbuterol Sulfate14$506
Atorvastatin Calcium73$416

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$1,417$62,75648 claims
AstraZenecaFarxiga$1,089$32,50235 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 553 adult health providers in Illinois.

Other adult health in Aurora

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →